Tamar Tadmor

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Clinical Practice

Top Venues

Hematological oncology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Tamar Tadmor, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment. Blood advances (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood advances 8 (14) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood advances 8 (14) (2024)
Martin H Ellis, Tamar Tadmor, Naama Yekutiel, Gabriel Chodick, Moti Levy, Giora Sharf, Nana Ben Zvi, Raanan Leef, Oren Feine, Oren Shavit
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice. Journal of clinical medicine 13 (12) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Martin H Ellis, Tamar Tadmor, Naama Yekutiel, Gabriel Chodick, Moti Levy, Giora Sharf, Nana Ben Zvi, Raanan Leef, Oren Feine, Oren Shavit
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice. Journal of clinical medicine 13 (12) (2024)
Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, Naomi Rahimi-Levene, Levy Ilana, Tamar Tadmor, Maya Koren-Michowitz
Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study. Cancer medicine (2023)
Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach
The course of patients with hairy cell leukemia during the omicron surge of the Covid-19 pandemic. Hematological oncology (2023)
Natalia Kreiniz, Nasren Eiza, Tamar Tadmor, Ilana Levy Yurkovski, Sarah Matarasso Greenfeld, Adi Sabag, Raeda Mubariki, Celia Suriu, Ekaterina Votinov, Elias Toubi, Zahava Vadasz
The Involvement of LAG-3 positive Plasma Cells in the Development of Multiple Myeloma. International journal of molecular sciences 25 (1) (2023)
Natalia Kreiniz, Nasren Eiza, Tamar Tadmor, Ilana Levy Yurkovski, Sarah Matarasso Greenfeld, Adi Sabag, Raeda Mubariki, Celia Suriu, Ekaterina Votinov, Elias Toubi, Zahava Vadasz
The Involvement of LAG-3 positive Plasma Cells in the Development of Multiple Myeloma. International journal of molecular sciences 25 (1) (2023)
Natalia Kreiniz, Nasren Eiza, Tamar Tadmor, Ilana Levy Yurkovski, Sarah Matarasso Greenfeld, Adi Sabag, Raeda Mubariki, Celia Suriu, Ekaterina Votinov, Elias Toubi, Zahava Vadasz
The Involvement of LAG-3 positive Plasma Cells in the Development of Multiple Myeloma. International journal of molecular sciences 25 (1) (2023)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Theodoros P Vassilakopoulos, Fotios P Panitsas, Zois Mellios, John Apostolidis, Michalis Michael, Ronit Gurion, Burhan Ferhanoğlu, Eleftheria Hatzimichael, Stamatios Karakatsanis, Maria Dimou, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Hara Giatra, Nick Kanellias, Ayman Sayyed, Tamar Tadmor, Olga Meltem Akay, Maria K Angelopoulou, Netanel Horowitz, Maria Bakiri, Gerassimos A Pangalis, Panayiotis Panayiotidis, Sotirios G Papageorgiou
INCIDENCE AND RISK FACTORS FOR CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA. Hematological oncology (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Tamir Shragai, Hila Magen, Noa Lavi, Moshe E E Gatt, Svetlana Trestman, Miri Zektser, Chezi Ganzel, Osnat Jarchowsky, Tamar Berger, Tamar Tadmor, Merav Leiba, Katrin Hertzog-Tzarfaty, Netanel Horowitz, Michael Shapira, David Varssano, Yoav Berger, Shahar Frenkel, Mark Krauthammer, Irit Avivi, Efrat Luttwak, Yael C Cohen, null null
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study. British journal of haematology (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David John Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, Jose Antonio Garcia-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K Hakobyan, Yair Herishanu, Jose-Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P Kater, Sabina Kersting, Jorge Labrador-Gomez, Deepesh P Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto López-García, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten Utoft Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Caterina Ilari, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia 35 (12) (2021)
Tamar Tadmor, Ohad Benjamini, Andrei Braester, Galia Rahav, Lior Rokach
Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia. Leukemia 35 (9) (2021)
Tamar Tadmor, Ilana Levy Yurkovski
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents. Cancers 13 (20) (2021)
Yair Herishanu, Galia Rahav, Shai Levi, Andrei Braester, Gilad Itchaki, Osnat Bairey, Najib Dally, Lev Shvidel, Tomer Ziv-Baran, Aaron Polliack, Tamar Tadmor, Ohad Benjamini
Efficacy of a Third BNT162b2 mRNA COVID-19 Vaccine Dose in Patients with CLL who Failed Standard Two-dose Vaccination. Blood (2021)
Raffaella Marcheselli, Alessia Bari, Tamar Tadmor, Luigi Marcheselli, Maria Christina Cox, Robel Papotti, Angela Ferrari, Luca Baldini, Paolo Gobbi, Ilana Levy, Giuseppe Pugliese, Massimo Federico, Aaron Polliack, Samantha Pozzi, Stefano Sacchi
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma. Hematological oncology 38 (4) (2020)
Natalia Kreiniz, Maya Garty-Ofir, Jacob Bejar, Aaron Polliack, Tamar Tadmor
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen. Hematological oncology 39 (1) (2020)
Tamir Shragai, Moshe E E Gatt, Noa Lavie, Iuliana Vaxman, Tamar Tadmor, Ory Rouvio, Miri Zektser, Nethanel Horowitz, Hila Magen, Mouna Ballan, Celia Suru, Efrat Luttwak, Shai Levi, Tomer Ziv-Baran, Irit Avivi, Yael C Cohen
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review. European journal of haematology 106 (2) (2020)
Yair Herishanu, Tamar Tadmor, Andrei Braester, Osnat Bairey, Ariel Aviv, Naomi Rahimi-Levene, Riva Fineman, Itai Levi, Mona Yuklea, Rosa Ruchlemer, Lev Shvidel, Aaron Polliack
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience. Hematological oncology 37 (2) (2019)
Regina Michelis, Tamar Tadmor, Masad Barhoum, Mona Shehadeh, Lev Shvidel, Ariel Aviv, Galia Stemer, Najib Dally, Naomi Rahimi-Levene, Mona Yuklea, Andrei Braester
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity. PloS one 14 (1) (2019)
Tamar Tadmor, Andrei Braester, Dally Najib, Ariel Aviv, Yair Herishanu, Mona Yuklea, Lev Shvidel, Naomi Rahimi-Levene, Rosa Ruchlemer, Ariela Arad, Claudia Fogl, Clara Henig, Mira Barak, Lee Magal, Aaron Polliack, Kelly Townsend, null null
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain. European journal of haematology 103 (4) (2019)
Natalia Kreiniz, Jacob Bejar, Aaron Polliack, Tamar Tadmor
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. Hematological oncology 36 (1) (2017)
Erel Joffe, N Ariela Arad, Osnat Bairey, Riva Fineman, Rosa Ruchlemer, Naomi Rahimi-Levene, Lev Shvidel, Uri Greenbaum, Ariel Aviv, Tamar Tadmor, Andrei Braester, Neta Goldschmidt, Aaron Polliack, Yair Herishanu
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival. Hematological oncology 36 (1) (2017)